HIGHLIGHTS
- who: Daye Cheng and collaborators from the Department of Transfusion, First Hospital of China Medical University, Shenyang, China have published the research: The Diagnostic Accuracy of HE4 in Lung Cancer: A Meta-Analysis, in the Journal: (JOURNAL) of 20/02/2015
- what: The authors found great heterogeneity among the included studies, and the result of Spearman approach showed that heterogeneity could not be explained by a threshold effect.
- how: SROC results showed that AUC of HE4 was 0.8557 indicating that HE4 may be able to differentiate lung cancer patients from non-lung . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.